|
Worthington Biochemical
dnacellulose Dnacellulose, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/DNA+Cellulose%2C+Double-Stranded/10__1128_slash_jb__06003___11-81-36-37 Average 91 stars, based on 1 article reviews
dnacellulose - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Cusabio
65901 mouse anti dsdna igg elisa kit 65901 Mouse Anti Dsdna Igg Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Mouse+anti-double+stranded+DNA+antibody+(IgG)+ELISA+Kit/pm38758648-183-140-146 Average 93 stars, based on 1 article reviews
65901 mouse anti dsdna igg elisa kit - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Bio X Cell
rat anti mouse cd16 32 clone 2 4g2 Rat Anti Mouse Cd16 32 Clone 2 4g2, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Anti-Dopamine+Receptor+D3+Rabbit+Monoclonal+Antibody/pm41742422-271-18-23 Average 98 stars, based on 1 article reviews
rat anti mouse cd16 32 clone 2 4g2 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
TargetMol
parp inhibitor olaparib ![]() Parp Inhibitor Olaparib, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/DNA+Damage+%26+Repair+Compound+Library/10__3390_slash_biomedicines13040958-83-24-35 Average 94 stars, based on 1 article reviews
parp inhibitor olaparib - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Boster Bio
mre11 ![]() Mre11, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Anti-Mre11+Antibody/pm41486457-247-54-55 Average 90 stars, based on 1 article reviews
mre11 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cusabio
sku dsd31 k01 ![]() Sku Dsd31 K01, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Human+anti-double+stranded+DNA(dsDNA)+antibody(IgG)+ELISA+Kit/pm37062567-116-74-76 Average 93 stars, based on 1 article reviews
sku dsd31 k01 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Cusabio
mouse anti dsdna elisa kit ![]() Mouse Anti Dsdna Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Mouse+anti-double+stranded+DNA+antibody(IgM)ELISA+Kit/pmc08553505-80-7-11 Average 93 stars, based on 1 article reviews
mouse anti dsdna elisa kit - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Boster Bio
anti dsba antibody ![]() Anti Dsba Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Human+Disulfide+oxidoreductase%2FDsbA+Recombinant+Protein/pmc12398576__42003_2025_8749_MOESM1_ESM-213-38-40 Average 93 stars, based on 1 article reviews
anti dsba antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
TargetMol
beas 2b human lung epithelia cells ![]() Beas 2b Human Lung Epithelia Cells, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/XRCC5+Protein%2C+Human%2C+Recombinant/pm41285311-177-0-31 Average 93 stars, based on 1 article reviews
beas 2b human lung epithelia cells - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Boster Bio
antibodies to ku80 pb9464 ![]() Antibodies To Ku80 Pb9464, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Anti-Ku80%2FXRCC5+Antibody+Picoband/pm37390710-118-29-38 Average 92 stars, based on 1 article reviews
antibodies to ku80 pb9464 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Boster Bio
monoclonal antibody ![]() Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Anti-Ku-80+XRCC5+Monoclonal+Antibody/pmc03406497-44-18-20 Average 90 stars, based on 1 article reviews
monoclonal antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Boster Bio
anti rabbit secondary antibody ![]() Anti Rabbit Secondary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/double-stranded+dna/Anti-Ku80+XRCC5+Rabbit+Monoclonal+Antibody/pm24604116-39-8-12 Average 93 stars, based on 1 article reviews
anti rabbit secondary antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Biomedicines
Article Title: Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in BRCA1/2-Proficient Cancer Cells
doi: 10.3390/biomedicines13040958
Figure Lengend Snippet: Figure 1. High-throughput screening shows that IDH1 inhibitor ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the PARP inhibitor Olaparib in A2780 cells using an FDA-approved drug library (TargetMol, #L1000) that contains 2040 approved small molecule drugs. (B) The relative cell viability of A2780 cells grown in the presence of 10 µM of FDA-approved drugs alone (upper) or FDA-approved drugs plus 10 µM of Olaparib for 72 h; cell viability was analyzed through CCK-8 assay. (C) Ivosidenib increases Olaparib sensitivity in BRCA1/2-WT breast and ovarian cancer cells. Indicated cells were treated with increasing concentrations of Olaparib (ola) in the presence or absence of 5 µM of ivosidenib (Ivo) for 72 h, followed by cell viability analysis. (D) Ivosidenib and Olaparib synergistically suppress cancer cell growth. Indicated cells were co-treated with serial dosages of Olaparib and ivosidenib for 72 h, followed by Bliss synergy analysis. (E) Ivosidenib and Olaparib synergistically inhibit clonogenic survival in BRCA1/2-WT cancer cells. The colony formation analysis indicated cells treated with 2 µM of ivosidenib, 2 µM of Olaparib, or their combination. Data are presented as means ± SD, n = 6. * p < 0.05 and *** p < 0.001 based on the two-tailed t-test.
Article Snippet: High-throughput screening shows that IDH1 inhibi r ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the
Techniques: High Throughput Screening Assay, Drug discovery, CCK-8 Assay, Two Tailed Test
Journal: Biomedicines
Article Title: Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in BRCA1/2-Proficient Cancer Cells
doi: 10.3390/biomedicines13040958
Figure Lengend Snippet: Figure 2. Ivosidenib (Ivo) greatly potentiates Olaparib (Ola)-induced DNA damage in BRCA1/2- proficient cells. (A) Ivosidenib enhances Olaparib-induced γH2AX formation in BRCA1/2-WT cancer cells. Indicated cells were treated with 50 µM of Ola, 10 µM of Ivo, or their combination for 48 h, followed by Western blot analysis of γH2AX. (B) Ivosidenib delayed the reduction of γH2AX after Olaparib treatment. A2780 cells were treated with 100 µM for 48 h and then released into normal culture medium in the presence or absence of Ivo for indicated time points, followed by Western blot analysis of γH2AX. (C) Ivosidenib increases Olaparib-caused DNA damage. A2780 cells were treated with 50 µM of Ola, 10 µM of Ivo, or their combination for 48 h, followed by measuring the DNA damage through comet assay. Data are presented as means ± SD.
Article Snippet: High-throughput screening shows that IDH1 inhibi r ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the
Techniques: Western Blot, Single Cell Gel Electrophoresis
Journal: Biomedicines
Article Title: Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in BRCA1/2-Proficient Cancer Cells
doi: 10.3390/biomedicines13040958
Figure Lengend Snippet: Figure 3. Ivosidenib (Ivo) treatment suppresses the repair of Olaparib (Ola)-induced DSBs. Ivosidenib inhibits HR repair. (A,B) Ivosidenib A2780 cells were treated with 50 of µM Ola, 10 µM of Ivo, or their combination for 48 h, followed by immunofluorescence analysis of Rad51/γH2AX (A) or RPA2/γH2AX (B). (C) Cells were treated as indicated for 48 h, followed by Western blot analysis of pRPA2 S4/8. Data were are presented as means ± SD. ** p < 0.01 and *** p < 0.001 according to the two2-tailed t-test.
Article Snippet: High-throughput screening shows that IDH1 inhibi r ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the
Techniques: Immunofluorescence, Western Blot
Journal: Biomedicines
Article Title: Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in BRCA1/2-Proficient Cancer Cells
doi: 10.3390/biomedicines13040958
Figure Lengend Snippet: Figure 5. YTHDC2 knockdown suppresses HR repair. (A) Schematic diagram of HR repair reporter system (DR-GFP). (B,C) Silencing of YTHDC2 decreases HR repair. QU20S-DRGFP cells were transfected with control (ctrl) or YTHDC2 siRNA and, 24 h later, cells were transfected with pCBASceI plasmid to induce endonuclease-induced DSB, followed by flow cytometry analysis of GFP expression 48 h after pCBASceI expression (B). A2780 cells were transfected with control (Ctrl) or YTHDC2 siRNA; cells were then treated with 50 µM of Olaparib for 48 h, followed by immunofluorescence analysis of Rad51/γH2AX (C). Data are presented as means ± SD. *** p < 0.001 according to the two-tailed t-test.
Article Snippet: High-throughput screening shows that IDH1 inhibi r ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the
Techniques: Knockdown, Transfection, Control, Plasmid Preparation, Flow Cytometry, Expressing, Immunofluorescence, Two Tailed Test
Journal: Biomedicines
Article Title: Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in BRCA1/2-Proficient Cancer Cells
doi: 10.3390/biomedicines13040958
Figure Lengend Snippet: Figure 7. Combination treatment of ivosidenib (Ivo) and Olaparib (Ola) produces synergistic anti- tumor efficacy in BRCA1/2-proficient ovarian cancers. (A–C) Ivosidenib and Olaparib synergistically suppress tumor growth. A2780 xenograft bearing mice treated with Ola (100 mg/kg, orally) and Ivo (100 mg/kg, orally) and tumor growth curve (A), tumor image (B), and tumor weights (C) are shown. (D,E) Co-treatment with ivosidenib and Olaparib greatly induces DSBs and reduces proliferation in A2780 xenograft tumors. Immunohistochemistry analysis of γH2AX (D) and Ki67 (E) in tumors treated as indicated. Data are presented as means ± SD. *** p < 0.001 according to the two-tailed t-test.
Article Snippet: High-throughput screening shows that IDH1 inhibi r ivosidenib greatly sensitizes BRCA1/2-proficient cancer cells to PARPi. (A) The workflow for screening sensitizer drugs for the
Techniques: Immunohistochemistry, Two Tailed Test
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Article Title: Quercetin inhibits DNA damage responses to induce apoptosis via SIRT5/PI3K/AKT pathway in non-small cell lung cancer.
doi: 10.1016/j.biopha.2023.115071
Figure Lengend Snippet: Fig. 5. Quercetin inhibited NHEJ and HR pathways phosphorylation. Total proteins lysis and extraction after A549 and H1299 cultured with 0, 12.5, 50, and 200 μM quercetin for 24 h. In NHEJ pathways (A) the expression of p-DNA-PKcsS2056 (B, C), KU70 (D, E) and KU80 (F, G), and in HR pathways (H) the phosphorylation of p- ATRS428 (I, J), p-Chek1S345 (K, L), p-ATMS1981 (M, N) and Chek2T68 (O, P) were detected by western blot in both A549 and H1299 cells. And the results were measured by ImageJ and expressed as protein expression relative to GAPDH (mean ± S.D., n = 3). #p > 0.05, *p < 0.05, * *p < 0.01, * **p < 0.001 relative to values in the respective 0 μM group (B, p = 0.0048, R2 =0.7844, F=9.700; C, p = 0.0002, R2 =0.9042, F=25.17; D, p = 0.0054, R2 =0.7782, F=9.358; E, p = 0.0045, R2 =0.7879, F=9.908; F, p = 0.0037, R2 =0.7990, F=10.60; G, p = 0.0016, R2 =0.8379, F=13.79; I, p = 0.0034, R2 =0.8028, F=10.85; J, p = 0.0032, R2 =0.8066, F=11.12; K, p = 0.0010, R2 =0.8564, F=15.91; L, p = 0.0016, R2 =0.8379, F=13.79; M, p = 0.0044, R2 =0.7898, F=10.02; N, p = 0.0065, R2 =0.7676, F=8.806; O, p = 0.0030, R2 =0.0.8087, F=11.27; P, p = 0.0026, R2 =0.8166, F=11.87), One-way ANOVA test. The mRNA in A549 (Q) and H1299 (R) cells was extracted and reverse transcribed to cDNA for RT-qPCR analysis (mean ± S.D., n = 3). #p > 0.05, *p < 0.05, * *p < 0.01, * **p < 0.001, * ** *p < 0.0001 relative to values in the respective 0 μM group, One-way ANOVA test.
Article Snippet: Antibodies to γ-H2AXS139, p-ATRS428 (AP0676) and p-CDK1T161 (AP0324) were from Abclonal Technology (Abclonal, Wuhan, China); antibodies to KU70 (AF0300) and p-Chek1Ser345 (AF3008) were from Affinity Biosciences (Affinity, Jiangsu, China);
Techniques: Phospho-proteomics, Lysis, Extraction, Cell Culture, Expressing, Western Blot, Reverse Transcription, Quantitative RT-PCR